Humacyte Inc (HUMA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.32 +0.14 (+4.40%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.21 -0.11 (-3.31%) 18:59 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 0 | 1,565 | 1,263 | 1,491 | 0 |
Gross Profit | N/A | 1,565 | 1,263 | 1,491 | N/A |
Operating Expenses | 100,047 | 86,143 | 82,471 | 66,091 | 0 |
Operating Income | -100,047 | -84,578 | -81,208 | -64,600 | N/A |
Interest Expense | 6,599 | 6,200 | 4,348 | 2,202 | 0 |
Other Income | -4,130 | 78,813 | 59,079 | 278 | 0 |
Pre-tax Income | -110,776 | -11,965 | -26,477 | -66,524 | 0 |
Net Income Continuous | -110,776 | -11,965 | -26,477 | -66,524 | N/A |
Net Income | $-110,776 | $-11,965 | $-26,477 | $-66,524 | $N/A |
EPS Basic Total Ops | -1.07 | -0.12 | -0.66 | -11.54 | N/A |
EPS Basic Continuous Ops | -1.07 | -0.12 | -0.66 | -11.54 | N/A |
EPS Diluted Total Ops | -1.07 | -0.12 | -0.66 | -11.54 | N/A |
EPS Diluted Continuous Ops | -1.07 | -0.12 | -0.66 | -11.54 | N/A |
EPS Diluted Before Non-Recurring Items | -0.93 | -0.86 | -2.06 | N/A | N/A |
EBITDA(a) | $-91,846 | $-74,822 | $-71,990 | $-56,249 | $N/A |